Abstract 4689: Dynamic and defective repair of extrachromosomal DNA drives genome instability in cancer

Abstract Extrachromosomal DNA (ecDNA) is megabase-sized circular DNA amplified exclusively in tumor cells, driving poor outcomes and therapeutic resistance. EcDNA represents a distinct form of genome instability associated with heightened replication stress and DNA damage. However, how ecDNA manages these elevated damage levels remains unclear. Here, we used long-read sequencing and live-cell imaging to investigate DNA damage repair dynamics and genomic patterns in isogenic cell lines harboring either ecDNA or homogeneously staining region (HSR). We found that damaged ecDNAs are preferentially sequestered into micronuclei following induction of double-strand breaks. This process triggers additional DNA damage beyond the initial lesions and impairs homologous recombination (HR) during knock-in by CRISPR-Cas9. Structural variant analyses further revealed that although ecDNA damage initiates HR repair, the process is frequently incomplete or aberrant. Analysis of whole-genome sequencing data from 14,778 tumors across 39 cancer types in the Genomics England cohort confirmed that ecDNA-positive cancers exhibit enriched HR deficiency (HRD) mutational signatures, even after excluding cases with canonical HRD driver mutations. Together, these findings delineate the dynamic and error-prone repair of ecDNA, linking it to HRD-associated genomic alterations. Our study exposes vulnerabilities of ecDNA-positive cancers that may be therapeutically exploited through synthetic lethality related to HRD. Citation Format: Shu Zhang, Yanbo Wang, Thomas B. Watkins, Xiaowei Yan, Aditi Gnanasekar, Jun Tang, Ivy T. Wong, Howard Y. Chang, Paul S. Mischel. Dynamic and defective repair of extrachromosomal DNA drives genome instability in cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4689.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-4689
Primary Topic
Cancer Genomics and Diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 4689: Dynamic and defective repair of extrachromosomal DNA drives genome instability in cancer

Aditi Gnanasekar, Paul S. Mischel, Ivy Tsz-Lo Wong, Thomas B.K. Watkins et al.
Cancer Research
Cancer Genomics and Diagnostics
article

Abstract 4689: Dynamic and defective repair of extrachromosomal DNA drives genome instability in cancer

Aditi Gnanasekar, Paul S. Mischel, Ivy Tsz-Lo Wong, Thomas B.K. Watkins, Shu Zhang, Xiaowei Yan, Yanbo Wang, Jun Tang, Howard Y. Chang
article en

Abstract

Abstract Extrachromosomal DNA (ecDNA) is megabase-sized circular DNA amplified exclusively in tumor cells, driving poor outcomes and therapeutic resistance. EcDNA represents a distinct form of genome instability associated with heightened replication stress and DNA damage. However, how ecDNA manages these elevated damage levels remains unclear. Here, we used long-read sequencing and live-cell imaging to investigate DNA damage repair dynamics and genomic patterns in isogenic cell lines harboring either ecDNA or homogeneously staining region (HSR). We found that damaged ecDNAs are preferentially sequestered into micronuclei following induction of double-strand breaks. This process triggers additional DNA damage beyond the initial lesions and impairs homologous recombination (HR) during knock-in by CRISPR-Cas9. Structural variant analyses further revealed that although ecDNA damage initiates HR repair, the process is frequently incomplete or aberrant. Analysis of whole-genome sequencing data from 14,778 tumors across 39 cancer types in the Genomics England cohort confirmed that ecDNA-positive cancers exhibit enriched HR deficiency (HRD) mutational signatures, even after excluding cases with canonical HRD driver mutations. Together, these findings delineate the dynamic and error-prone repair of ecDNA, linking it to HRD-associated genomic alterations. Our study exposes vulnerabilities of ecDNA-positive cancers that may be therapeutically exploited through synthetic lethality related to HRD. Citation Format: Shu Zhang, Yanbo Wang, Thomas B. Watkins, Xiaowei Yan, Aditi Gnanasekar, Jun Tang, Ivy T. Wong, Howard Y. Chang, Paul S. Mischel. Dynamic and defective repair of extrachromosomal DNA drives genome instability in cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 4689.

Cancer ResearchVol. 86(7_Supplement)
Stratford University (US), Stanford Medicine (US), Stanford University (US)
No poverty
Openalex Percentile: Top 32%
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.